Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-03-16

Clinical Trial Update: The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) [NA]

View source ↗

Summary

This clinical trial update indicates the study comparing Cosopt (dorzolamide/timolol) and Xalacom (latanoprost/timolol) in open-angle glaucoma and ocular hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosopt (dorzolamide/timolol)
  • Xalacom (latanoprost/timolol)

Snippet

Sponsor: Meir Medical Center | Conditions: Open-Angle Glaucoma, Ocular Hypertension | NA | Status: WITHDRAWN